Top companies in Americas by Price to Sales Ratio (P/S)

This ranking features the top 4,256 companies in Americas ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 43,471.93, for January 15, 2025.

Americas

All sectors

#	Name	Price to Sales Ratio (P/S)	Reported Date	Stock Price	Change	Country
1	Inhibikase Therapeutics, Inc. 1 IKT	184,503,984.00	Jan. 14, 2025	USD 2.66	NA	United States
2	Gatos Silver, Inc. 2 GATO	73,737.44	Jan. 14, 2025	USD 14.86	5.02%	United States
3	LQwD FinTech Corp. 3 LQWD.V	60,971.89	Jan. 14, 2025	USD 1.23	13.06%	Canada
4	Benitec Biopharma Inc. 4 BNTC	40,164.37	Jan. 14, 2025	USD 10.38	-0.10%	United States
5	Eco (Atlantic) Oil & Gas Ltd. 5 ECO.L	32,869.28	Jan. 14, 2025	USD 0.15	1.75%	Canada
6	Greenwich LifeSciences, Inc. 6 GLSI	29,258.97	Jan. 14, 2025	USD 12.06	-1.63%	United States
7	DatChat, Inc. 7 DATS	28,515.59	Jan. 14, 2025	USD 4.88	-9.96%	United States
8	Forte Biosciences, Inc. 8 FBRX	15,578.39	Jan. 14, 2025	USD 14.62	-8.62%	United States
9	Immix Biopharma, Inc. 9 IMMX	11,499.83	Jan. 14, 2025	USD 2.00	-5.66%	United States
10	Bullfrog AI Holdings, Inc. Common Stock 10 BFRG	10,613.47	Jan. 14, 2025	USD 2.10	-0.47%	United States
11	Cadrenal Therapeutics, Inc. Common Stock 11 CVKD	10,296.97	Jan. 14, 2025	USD 15.99	NA	United States
12	Revolution Medicines, Inc. 12 RVMD	9,919.66	Jan. 14, 2025	USD 39.83	-6.44%	United States
13	Allogene Therapeutics, Inc. 13 ALLO	9,362.10	Jan. 14, 2025	USD 1.92	-1.54%	United States
14	Viking Therapeutics, Inc. 14 VKTX	8,672.07	Jan. 14, 2025	USD 33.93	-12.73%	United States
15	Altimmune, Inc. 15 ALT	8,521.27	Jan. 14, 2025	USD 6.23	-8.11%	United States
16	NRx Pharmaceuticals, Inc. 16 NRXP	7,709.99	Jan. 14, 2025	USD 5.10	3.87%	United States
17	Joby Aviation, Inc. 17 JOBY	5,403.03	Jan. 14, 2025	USD 7.86	-1.26%	United States
18	Akero Therapeutics, Inc. 18 AKRO	5,375.03	Jan. 14, 2025	USD 21.87	-3.36%	United States
19	NET Power Inc. 19 NPWR	5,297.49	Jan. 14, 2025	USD 8.80	-3.93%	United States
20	Zentek Ltd. 20 ZEN.V	4,907.32	Jan. 14, 2025	USD 1.04	3.69%	Canada
21	Rezolute, Inc. 21 RZLT	4,715.37	Jan. 14, 2025	USD 4.72	-0.63%	United States
22	Viridian Therapeutics, Inc. 22 VRDN	4,422.27	Jan. 14, 2025	USD 16.86	-5.12%	United States
23	Eve Holding, Inc. 23 EVEX	4,146.45	Jan. 14, 2025	USD 4.20	-3.45%	United States
24	Gaxos.ai Inc. 24 GXAI	3,974.19	Jan. 14, 2025	USD 1.71	2.40%	United States
25	Context Therapeutics Inc. 25 CNTX	3,918.10	Jan. 14, 2025	USD 0.99	-3.87%	United States
26	Tenax Therapeutics, Inc. 26 TENX	3,785.72	Jan. 14, 2025	USD 6.43	4.38%	United States
27	VirnetX Holding Corp 27 VHC	3,579.95	Jan. 14, 2025	USD 7.68	6.22%	United States
28	Checkpoint Therapeutics, Inc. 28 CKPT	3,293.60	Jan. 14, 2025	USD 3.17	-0.94%	United States
29	Crinetics Pharmaceuticals, Inc. 29 CRNX	3,179.32	Jan. 14, 2025	USD 35.62	-8.62%	United States
30	89bio, Inc. 30 ETNB	3,155.62	Jan. 14, 2025	USD 6.28	-0.47%	United States
31	INmune Bio, Inc. 31 INMB	3,143.74	Jan. 14, 2025	USD 5.96	-8.87%	United States
32	Trump Media & Technology Group Corp. 32 DJT	2,533.08	Jan. 14, 2025	USD 39.35	-8.30%	United States
33	Quantum Computing, Inc. 33 QUBT	2,480.95	Jan. 14, 2025	USD 7.43	13.96%	United States
34	AST SpaceMobile, Inc. 34 ASTS	2,373.51	Jan. 14, 2025	USD 20.48	-2.80%	United States
35	NextDecade Corporation 35 NEXT	2,302.57	Jan. 14, 2025	USD 8.05	3.34%	United States
36	Sera Prognostics, Inc. 36 SERA	2,288.63	Jan. 14, 2025	USD 6.37	0.63%	United States
37	Enliven Therapeutics, Inc. 37 ELVN	2,271.95	Jan. 14, 2025	USD 20.46	-7.29%	United States
38	Immunovant, Inc. 38 IMVT	2,238.96	Jan. 14, 2025	USD 22.88	0.57%	United States
39	Banco Macro S.A. 39 BMA.BA	2,118.12	Jan. 14, 2025	USD 13.14	7.34%	Argentina
40	Lightwave Logic, Inc. 40 LWLG	2,108.20	Jan. 14, 2025	USD 1.95	2.63%	United States
41	Quince Therapeutics, Inc. 41 QNCX	2,090.08	Jan. 14, 2025	USD 1.71	-1.16%	United States
42	Alfa Holdings S.A. 42 RPAD5.SA	2,050.47	Jan. 13, 2025	USD 1.46	0.12%	Brazil
43	Trevi Therapeutics, Inc. 43 TRVI	1,995.50	Jan. 14, 2025	USD 3.93	-1.50%	United States
44	Chimerix, Inc. 44 CMRX	1,906.98	Jan. 14, 2025	USD 3.37	1.81%	United States
45	Celcuity Inc. 45 CELC	1,702.50	Jan. 14, 2025	USD 10.53	-2.95%	United States
46	Cytokinetics, Incorporated 46 CYTK	1,658.21	Jan. 14, 2025	USD 45.23	-3.17%	United States
47	Tyra Biosciences, Inc. 47 TYRA	1,606.80	Jan. 14, 2025	USD 15.94	5.56%	United States
48	Corvus Pharmaceuticals, Inc. 48 CRVS	1,332.16	Jan. 14, 2025	USD 5.10	-1.92%	United States
49	Acelyrin, Inc. 49 SLRN	1,269.18	Jan. 14, 2025	USD 2.10	-2.33%	United States
50	Denison Mines Corp. 50 DML.TO	1,226.16	Jan. 14, 2025	USD 1.92	-0.15%	Canada

1 2 3 4 … 86

Frequently Asked Questions

Which company in Americas has the highest Price to Sales Ratio (P/S) ?

The company in Americas with the highest Price to Sales Ratio (P/S) is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at 184,503,984.00.
Which company in Americas has the lowest Price to Sales Ratio (P/S) ?

The company in Americas with the lowest Price to Sales Ratio (P/S) is LM Funding America, Inc. (NasdaqCM: LMFA) at 0.00.

What are the top 10 companies in Americas by Price to Sales Ratio (P/S) ?

The top 10 companies in Americas by Price to Sales Ratio (P/S) are Inhibikase Therapeutics, Inc., Gatos Silver, Inc., LQwD FinTech Corp., Benitec Biopharma Inc., Eco (Atlantic) Oil & Gas Ltd., Greenwich LifeSciences, Inc., DatChat, Inc., Forte Biosciences, Inc., Immix Biopharma, Inc. and Bullfrog AI Holdings, Inc. Common Stock.
What are the bottom 10 companies in Americas by Price to Sales Ratio (P/S) ?

The bottom 10 companies in Americas by Price to Sales Ratio (P/S) are LM Funding America, Inc., Comtech Telecommunications Corp., Tennessee Valley Authority PARRS D 2028, Air Industries Group, Snail, Inc. Class A Common Stock, Streamline Health Solutions, Inc., Ispire Technology Inc., Grupo Casas Bahia S.A., Kopin Corporation and Transat A.T. Inc..